Early perturbation in feeding behaviour and energy homeostasy in olanzapine-treated rats

Psychopharmacology

Volumn 206, Issue 1, 2009, Pages 167-176

  Victoriano, Montserrat ^a,b   Hermier, Dominique ^a,b   Even, Patrick C ^a,b   Fromentin, Gilles ^a,b   Huneau, Jean François ^a,b   Tomé, Daniel ^a,b   De Beaurepaire, Renaud ^c  

^a INRA Institut National de la Recherche Agronomique   (France)

^b AGROPARISTECH   (France)

^c Centre Hospitalier Paul Guiraud   (France)

Author keywords

Antipsychotic; Feeding pattern; Metabolic syndrome; Olanzapine; Rat model

Indexed keywords

HALOPERIDOL; OLANZAPINE;

ANIMAL EXPERIMENT; ARTICLE; BODY COMPOSITION; CONTROLLED STUDY; DRUG EFFECT; DRUG INHIBITION; DRUG MECHANISM; ENERGY METABOLISM; FEEDING BEHAVIOR; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; HYPERGLYCEMIA; INSULIN RESISTANCE; MALE; NONHUMAN; OBESITY; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL; RAT;

ADIPOSITY; ANIMALS; ANTIPSYCHOTIC AGENTS; BENZODIAZEPINES; BLOOD GLUCOSE; EATING; ENERGY METABOLISM; FEEDING BEHAVIOR; GLUCOSE TOLERANCE TEST; HALOPERIDOL; MALE; RATS; RATS, SPRAGUE-DAWLEY; SCHIZOPHRENIC PSYCHOLOGY; TIME FACTORS; WEIGHT GAIN;

EID: 69049106362     PISSN: 00333158     EISSN: 14322072     Source Type: Journal    
DOI: 10.1007/s00213-009-1593-5     Document Type: Article

References (49)

1. VL Albaugh CR Henry NT Bello A Hajnal SL Lynch B Halle CJ Lynch 2006 Hormonal and metabolic effects of olanzapine and clozapine related to body weight in rodents Obesity (Silver Spring) 14 36 51
2. DB Allison JL Mentore M Heo LP Chandler JC Cappelleri MC Infante PJ Weiden 1999 Antipsychotic-induced weight gain: a comprehensive research synthesis Am J Psychiatry 156 1686 1696
3. American Diabetes Association American Psychiatric Association 2004 Consensus development conference on antipsychotic drugs and obesity and diabetes Diabetes Care 27 596 601
4. AA Arjona SX Zhang B Adamson RJ Wurtman 2004 An animal model of antipsychotic-induced weight gain Behav Brain Res 152 121 127
5. T Baptista 1999 Body weight gain induced by antipsychotic drugs: mechanisms and management Acta Psychiatr Scand 100 3 16
6. T Baptista EA de Baptista J Lalonde J Plamondon NM Kin S Beaulieu R Joober D Richard 2004 Comparative effects of the antipsychotics sulpiride and risperidone in female rats on energy balance, body composition, fat morphology and macronutrient selection Prog Neuropsychopharmacol Biol Psychiatry 28 1305 1311
7. F Bellisle R McDevitt AM Prentice 1997 Meal frequency and energy balance Br J Nutr 77 Suppl 1 S57 S70
8. JC Bittencourt F Presse C Arias C Peto J Vaughan JL Nahon W Vale PE Sawchenko 1992 The melanin-concentrating hormone system of the rat brain: an immuno- and hybridization histochemical characterization J Comp Neurol 319 218 245
9. M Burstein R Morlin 1970 Precipitation of serum lipoproteins by anionic detergents in the presence of bivalent cations Rev Eur Etud Clin Biol 15 109 113
10. CJ Bushe BE Leonard 2007 Blood glucose and schizophrenia: a systematic review of prospective randomized clinical trials J Clin Psychiatry 68 1682 1690
11. YC Chagnon C Merette RH Bouchard C Emond MA Roy M Maziade 2004 A genome wide linkage study of obesity as secondary effect of antipsychotics in multigenerational families of eastern Quebec affected by psychoses Mol Psychiatry 9 1067 1074
12. YC Chagnon A Bureau D Gendron RH Bouchard C Merette MA Roy M Maziade 2007 Possible association of the pro-melanin-concentrating hormone gene with a greater body mass index as a side effect of the antipsychotic olanzapine Am J Med Genet B Neuropsychiatr Genet 144B 1063 1069
13. PG Clifton IN Rusk SJ Cooper 1991 Effects of dopamine D1 and dopamine D2 antagonists on the free feeding and drinking patterns of rats Behav Neurosci 105 272 281
14. GD Cooper LC Pickavance JP Wilding JC Halford AJ Goudie 2005 A parametric analysis of olanzapine-induced weight gain in female rats Psychopharmacology (Berl) 181 80 89
15. GD Cooper LC Pickavance JP Wilding JA Harrold JC Halford AJ Goudie 2007 Effects of olanzapine in male rats: enhanced adiposity in the absence of hyperphagia, weight gain or metabolic abnormalities J Psychopharmacol 21 405 413
16. GD Cooper JA Harrold JC Halford AJ Goudie 2008 Chronic clozapine treatment in female rats does not induce weight gain or metabolic abnormalities but enhances adiposity: implications for animal models of antipsychotic-induced weight gain Prog Neuropsychopharmacol Biol Psychiatry 32 428 436
17. Cooper G, Goudie A, Halford J (2009) Acute effects of olanzapine on behavioural expression including the behavioural satiety sequence in female rats. J Psychopharmacol (in press). doi: 10.1177/0269881109102543
18. N Davoodi M Kalinichev SA Korneev PG Clifton 2009 Hyperphagia and increased meal size are responsible for weight gain in rats treated sub-chronically with olanzapine Psychopharmacology (Berl) 203 693 702
19. BW Dunlop M Sternberg LS Phillips J Andersen E Duncan 2003 Disturbed glucose metabolism among patients taking olanzapine and typical antipsychotics Psychopharmacol Bull 37 99 117
20. MJ Fell N Anjum K Dickinson KM Marshall LM Peltola S Vickers S Cheetham JC Neill 2007 The distinct effects of subchronic antipsychotic drug treatment on macronutrient selection, body weight, adiposity, and metabolism in female rats Psychopharmacology (Berl) 194 221 231
21. S Feurte D Tome DW Gietzen PC Even S Nicolaidis G Fromentin 2002 Feeding patterns and meal microstructure during development of a taste aversion to a threonine devoid diet Nutr Neurosci 5 269 278
22. P Fossati L Prencipe 1982 Serum triglycerides determined colorimetrically with an enzyme that produces hydrogen peroxide Clin Chem 28 2077 2080
23. S Gebhardt M Haberhausen JC Krieg H Remschmidt M Heinzel-Gutenbrunner J Hebebrand FM Theisen 2007 Clozapine/olanzapine-induced recurrence or deterioration of binge eating-related eating disorders J Neural Transm 114 1091 1095
24. D Georgescu RM Sears JD Hommel M Barrot CA Bolanos DJ Marsh MA Bednarek JA Bibb E Maratos-Flier EJ Nestler RJ DiLeone 2005 The hypothalamic neuropeptide melanin-concentrating hormone acts in the nucleus accumbens to modulate feeding behavior and forced-swim performance J Neurosci 25 2933 2940
25. D Gothelf B Falk P Singer M Kairi M Phillip L Zigel I Poraz S Frishman N Constantini G Zalsman A Weizman A Apter 2002 Weight gain associated with increased food intake and low habitual activity levels in male adolescent schizophrenic in patients treated with olanzapine Am J Psychiatry 159 1055 1057
26. AJ Goudie GD Cooper JC Halford 2005 Antipsychotic-induced weight gain Diabetes Obes Metab 7 478 487
27. AW Hartfield NA Moore PG Clifton 2003 Effects of clozapine, olanzapine and haloperidol on the microstructure of ingestive behaviour in the rat Psychopharmacology (Berl) 167 115 122
28. DC Henderson PM Doraiswamy 2008 Prolactin-related and metabolic adverse effects of atypical antipsychotic agents J Clin Psychiatry 69 Suppl 1 32 44
29. M Kalinichev C Rourke AJ Daniels MK Grizzle CS Britt DM Ignar DN Jones 2005 Characterisation of olanzapine-induced weight gain and effect of aripiprazole vs olanzapine on body weight and prolactin secretion in female rats Psychopharmacology (Berl) 182 220 231
30. DL Kelly RR Conley RC Love JA Morrison RP McMahon 2008 Metabolic risk with second-generation antipsychotic treatment: a double-blind randomized 8-week trial of risperidone and olanzapine Ann Clin Psychiatry 20 71 78
31. M Kluge A Schuld H Himmerich M Dalal A Schacht PM Wehmeier D Hinze-Selch T Kraus RW Dittmann T Pollmacher 2007 Clozapine and olanzapine are associated with food craving and binge eating: results from a randomized double-blind study J Clin Psychopharmacol 27 662 666
32. MD Lee PG Clifton 2002 Meal patterns of free feeding rats treated with clozapine, olanzapine, or haloperidol Pharmacol Biochem Behav 71 147 154
33. JP Lindenmayer P Czobor J Volavka L Citrome B Sheitman JP McEvoy TB Cooper M Chakos JA Lieberman 2003 Changes in glucose and cholesterol levels in patients with schizophrenia treated with typical or atypical antipsychotics Am J Psychiatry 160 290 296
34. DR Matthews JP Hosker AS Rudenski BA Naylor DF Treacher RC Turner 1985 Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man Diabetologia 28 412 419
35. J Minet-Ringuet PC Even B Guesdon D Tome R de Beaurepaire 2005 Effects of chronic neuroleptic treatments on nutrient selection, body weight, and body composition in the male rat under dietary self-selection Behav Brain Res 163 204 211
36. J Minet-Ringuet PC Even M Goubern D Tome R de Beaurepaire 2006a Long term treatment with olanzapine mixed with the food in male rats induces body fat deposition with no increase in body weight and no thermogenic alteration Appetite 46 254 262
37. J Minet-Ringuet PC Even M Lacroix D Tome R de Beaurepaire 2006b A model for antipsychotic-induced obesity in the male rat Psychopharmacology (Berl) 187 447 454
38. J Minet-Ringuet PC Even P Valet C Carpene V Visentin D Prevot D Daviaud A Quignard-Boulange D Tome R de Beaurepaire 2007 Alterations of lipid metabolism and gene expression in rat adipocytes during chronic olanzapine treatment Mol Psychiatry 12 562 571
39. JL Nahon 2006 The melanocortins and melanin-concentrating hormone in the central regulation of feeding behavior and energy homeostasis C R Biol 329 623 638 discussion 653-5
40. JW Newcomer 2007 Antipsychotic medications: metabolic and cardiovascular risk J Clin Psychiatry 68 Suppl 4 8 13
41. JW Newcomer DW Haupt 2006 The metabolic effects of antipsychotic medications Can J Psychiatry 51 480 491
42. JW Newcomer DW Haupt R Fucetola AK Melson JA Schweiger BP Cooper G Selke 2002 Abnormalities in glucose regulation during antipsychotic treatment of schizophrenia Arch Gen Psychiatry 59 337 345
43. A Ortega-Alvaro J Gibert-Rahola JA Mico 2006 Influence of chronic treatment with olanzapine, clozapine and scopolamine on performance of a learned 8-arm radial maze task in rats Prog Neuropsychopharmacol Biol Psychiatry 30 104 111
44. MR Rashidi S Mahboob R Sattarivand 2003 Effects of nibbling and gorging on lipid profiles, blood glucose and insulin levels in healthy subjects Saudi Med J 24 945 948
45. W Richmond 1973 Preparation and properties of a cholesterol oxidase from Nocardia sp. and its application to the enzymatic assay of total cholesterol in serum Clin Chem 19 1350 1356
46. JL Roerig JE Mitchell M de Zwaan RD Crosby BA Gosnell KJ Steffen SA Wonderlich 2005 A comparison of the effects of olanzapine and risperidone versus placebo on eating behaviors J Clin Psychopharmacol 25 413 418
47. P Trinder 1969 Determination of blood glucose using an oxidase-peroxidase system with a non-carcinogenic chromogen J Clin Pathol 22 158 161
48. NM Wallingford P Sinnayah FP Bymaster KM Gadde RK Krishnan AA McKinney RP Landbloom GD Tollefson MA Cowley 2008 Zonisamide prevents olanzapine-associated hyperphagia, weight gain, and elevated blood glucose in rats Neuropsychopharmacology 33 2922 2933
49. DA Wirshing JA Boyd LR Meng JS Ballon SR Marder WC Wirshing 2002 The effects of novel antipsychotics on glucose and lipid levels J Clin Psychiatry 63 856 865